Circulating leptin and insulin in obese patients with and without type 2 diabetes mellitus: Relation to ghrelin and oxidative stress

Diabetes Research and Clinical Practice

Volumn 94, Issue 3, 2011, Pages 434-441

  Hamed, Enas A ^a   Zakary, Madeha M ^a   Ahmed, Nagwa S ^a,b   Gamal, Rania M ^a  

^a Assiut University Faculty of Medicine   (Egypt)

^b Sohag University   (Egypt)

Author keywords

Ghrelin; Leptin; Obesity; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

GHRELIN; GLUCOSE; INSULIN; LEPTIN; LIPID PEROXIDE; NITRIC OXIDE;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FASTING BLOOD GLUCOSE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; POSTPRANDIAL BLOOD GLUCOSE;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GHRELIN; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; OBESITY; OXIDATIVE STRESS;

EID: 82955186986     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.08.023     Document Type: Article

References (48)

1. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
2. Karra E., Batterham R.L. The role of gut hormones in the regulation of body weight and energy homeostasis. Mol Cell Endocrinol 2010, 316(2):120-128.
3. Kahn S.E., Haffner S.M., Heise M.A., Herman W.H., Holman R.R., Jones N.P., et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006, 355(23):2427-2443.
4. Bagnasco M., Kalra P.S., Kalra S.P. Ghrelin and leptin pulse discharge in fed and fasted rats. Endocrinology 2002, 143:726-729.
5. Kojima M., Kangawa K. Drug insight: the functions of ghrelin and its potential as a multitherapeutic hormone. Nat Clin Pract Endocrinol Metab 2006, 2:80-88.
6. Ariyasu H., Takaya K., Hosoda H., Iwakura H., Ebihara K., Mori K., et al. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology 2002, 143:3341-3350.
7. Zigman J.M., Jones J.E., Lee C.E., Saper C.B., Elmquist J.K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 2006, 494:528-548.
8. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2002, 141:4325-4328.
9. Nagaya N., Uematsu M., Kojima M., Date Y., Nakazato M., Okumura H., et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 2001, 104:2034-2038.
10. Shimizu Y., Nagaya N., Isobe T., Imazu M., Okumura H., Hosoda H., et al. Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 2003, 9:774-778.
11. Tolle V., Kadem M., Bluet-Pajot M.T., Frere D., Foulon C., Bossu C., et al. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab 2003, 88:109-116.
12. Date Y., Nakazato M., Hashiguchi S., Dezaki K., Mondal M.S., Hosoda H., et al. Ghrelin is present in pancreatic β-cells of humans and rats and stimulates insulin secretion. Diabetes 2002, 51:124-129.
13. Konukoglu D., Serin O., Turhan M.S. Plasma leptin and its relationship with lipid peroxidation and nitric oxide in obese female patients with or without hypertension. Arch Med Res 2006, 37:602-606.
14. Hukshorn C.J., Lindeman J.H.N., Toet K.H., Saris W.H.M., Eilers P.H.C., Westerterp-Plantenga M.S., et al. Leptin and the pro-inflammatory state associated with human obesity. J Clin Endocrinol Metab 2004, 89(4):1773-1778.
15. Murata M., Okimura Y., Iida K., Matsumoto M., Sowa H., Kaji H., et al. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem 2002, 277:5667-5674.
16. Higgins S.C., Gueorguiev M., Korbonits M. Ghrelin, the peripheral hunger hormone. Ann Med 2007, 39:116-136.
17. Erdmann J., Lippl F., Wagenpfeil S., Schusdziarra V. Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes. Diabetes 2005, 54:1371-1378.
18. Wauters M., Considine R.V., Yudkin J.S., Peiffer F., De Leeuw I., Van Gaal L.F. Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion. Horm Metab Res 2003, 35:92-96.
19. Ahmad F.K., Zhiheng H., King G.L. Molecular targets of diabetic cardiovascular complications. Curr Drug Targets 2005, 6:487-494.
20. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010, 17:332-341.
21. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002, 159:1029-1039.
22. Grau A., Codony R., Rafecas M., Barroeta A.C., Guardiola F. Lipid hydroperoxide determination in dark chicken meat through a ferrous oxidation-xylenol orange method. J Agric Food Chem 2000, 48(9):4136-4143.
23. Ding A.H., Nathan C.F., Stuchr D.J. Release of reactive nitrogen intermediate from mouse peritoneal macrophage comparison of activating cytokines and evidence for independent production. J Immunol 1988, 141(7):2407-2412.
24. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
25. Vermes I., Steinmetz E., Schoorl J., van der Veen E.A., Tilders F.J. Increased plasma levels of immunoreactive beta-endorphin and corticotropin in non-insulin-dependent diabetes. Lancet 1985, 2(8457):725-726.
26. Flanagan D.E., Evans M.L., Monsod T.P., Rife F., Heptulla R.A., Tamborlane W.V., et al. The influence of insulin on circulating ghrelin. Am J Physiol 2003, 284:E313-E316.
27. Schaller G., Schmidt A., Pleiner J., Woloszczuk W., Wolzt M., Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes 2003, 52:16-20.
28. Lippl F., Kircher F., Erdmann J., Allescher H.D., Schusdziarra V. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach. Regul Pept 2004, 119:93-98.
29. Weigle D.S., Cummings D.E., Newby P.D., Breen P.A., Frayo R.S., Matthys C.C., et al. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J Clin Endocrinol Metab 2003, 88:1577-1586.
30. Ueno H., Dube M.G., Inui A., Kalra P.S., Kalra S.P. Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology 2004, 145:4176-4184.
31. Barazzoni R., Zanetti M., Stebel M., Biolo G., Cattin L., Guarnieri G. Hyperleptinemia prevents increased plasma ghrelin concentration during shortterm moderate caloric restriction in rats. Gastroenterology 2003, 124:1188-1192.
32. Lippl F., Erdmann J., Atmatzidis S., Schusdziarra V. Direct effect of leptin on gastric ghrelin secretion. Horm Metab Res 2005, 37:123-125.
33. Chan J.L., Bullen J., Lee J.H., Yiannakouris N., Mantzoros C.S. Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab 2004, 89:335-343.
34. Tschöp M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50:707-709.
35. Ritland L.M., Alekel D.L., Matvienko O.A., Hanson K.B., Stewart J.W., Hanson L.N., et al. Centrally located body fat is related to appetitive hormones in healthy postmenopausal women. Eur J Endocrinol 2008, 158(6):889-897.
36. Peterson R.M., Beeson L., Shulz E., Firek A., De Leon M., Balcazar H., et al. Impacting obesity and glycemic control using a culturally-sensitive diabetes education program in Hispanic patients with type 2 diabetes. Int J Body Compos Res 2010, 8(3):85-94.
37. Schöfl C., Horn R., Schill T., Schlosser H.W., Müller M.J., Brabant G. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87:4607-4610.
38. Korbonits M., Grossman A.B. Ghrelin - update on a novel hormonal system. Eur J Endocrinol 2004, 151(Suppl. 1):S67-S70.
39. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009, 15:914-920.
40. Trayhurn P., Hoggard N., Mercer J.G., Rayner D.V. Leptin: fundamental aspects. Int J Obes Relat Metab Disord 1999, 23(Suppl. 1):22-28.
41. Ruhl C.E., Everhart J.E. Leptin concentrations in the United States: relations with demographic and anthropometric measures. Am J Clin Nutr 2001, 74:295-301.
42. Shi H., Tzameli I., Bjørbaek C., Flier J.S. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem 2004, 279:34733-34740.
43. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009, 119(3):573-581.
44. Gomes V.A., Casella-Filho A., Chagas A.C., Tanus-Santos J.E. Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome. Nitric Oxide 2008, 19:345-350.
45. Sun Y. Free radical antioxidant enzymes and carcinogenesis. Free Radic Biol Med 1990, 8:583-599.
46. Mukhtar H., Elmets C.A. Photocarcinogenesis: mechanisms, models and human health implications. Photochem Photobiol 1996, 63:355-447.
47. Nakanishi S., Yamane K., Kamei N., Hideki N., Okubo M., Kohno N. A protective effect of adinopectin against oxidative stress in Japanese Americans: the association between adinopectin or leptin and urinary isoprostane. Metabolism 2005, 54:194-199.
48. Bouloumi{dotless}e A., Marumo T., Lafontan M., Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999, 13:1231-1238.